美亞控股(01116.HK)延期刊發年度業績
美亞控股(01116.HK)公布,由於需要額外時間收集及提供核數師要求的文件及資料,包括由獨立調查委員會擬備的調查報告,無法根據上市規則於9月30日或之前公佈2023年年度業績。
董事會經審慎考慮後認為,公司不宜公佈本年度未經審核的管理賬目,因為賬目須於現階段進行審核,而該等資料可能會令股東及潛在投資者產生混淆或誤導。董事會及管理層將繼續與核數師緊密合作,以協助完成餘下的審核程序,並在切實可行的情況下盡快公佈年度業績。
董事會會議原定於9月28日舉行,將於10月31日或之前續會。該股已於今年9月29日起停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.